SonoScape Medical Corp. (SHE:300633)
China
· Delayed Price · Currency is CNY 24.30
-1.35 (-5.26%)
Apr 29, 2026, 3:04 PM CST
SonoScape Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,340 | 2,290 | 2,000 | 2,108 | 1,752 | 1,435 | Upgrade
|
| Other Revenue | 19.39 | 19.39 | 14.2 | 12.65 | 10.73 | 9.27 | Upgrade
|
| Revenue | 2,360 | 2,309 | 2,014 | 2,120 | 1,763 | 1,445 | Upgrade
|
| Revenue Growth (YoY) | 20.11% | 14.65% | -5.02% | 20.29% | 22.02% | 24.20% | Upgrade
|
| Cost of Revenue | 946.96 | 919.9 | 786.29 | 720.3 | 624.18 | 533.13 | Upgrade
|
| Gross Profit | 1,413 | 1,389 | 1,228 | 1,400 | 1,138 | 911.46 | Upgrade
|
| Selling, General & Admin | 843.9 | 821.75 | 710.04 | 616.63 | 521.16 | 457.37 | Upgrade
|
| Research & Development | 485.4 | 495.78 | 472.93 | 384.26 | 328.96 | 263.06 | Upgrade
|
| Other Operating Expenses | -50.44 | -52.04 | -61.66 | -72.96 | -52.56 | -35.46 | Upgrade
|
| Operating Expenses | 1,291 | 1,278 | 1,127 | 942.27 | 817.47 | 695.26 | Upgrade
|
| Operating Income | 121.55 | 111.27 | 100.97 | 457.68 | 320.99 | 216.21 | Upgrade
|
| Interest Expense | -4.16 | -4.16 | -6.7 | -5.05 | -3.7 | -5.55 | Upgrade
|
| Interest & Investment Income | 37.11 | 37.83 | 46.15 | 46.67 | 27.09 | 17.67 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.51 | 4.51 | 1.63 | 6.84 | 17.97 | -7.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -35.89 | -3.07 | -3.09 | -3.77 | -2.21 | 37.65 | Upgrade
|
| EBT Excluding Unusual Items | 123.12 | 146.38 | 138.96 | 502.36 | 360.14 | 258.92 | Upgrade
|
| Impairment of Goodwill | - | - | -55.91 | -15.44 | - | -36.98 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.4 | 0.16 | 3.56 | -12.84 | -3.93 | 3.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | 0.03 | 0.05 | 0.02 | -0.74 | -0.19 | Upgrade
|
| Asset Writedown | -1.21 | -1.21 | -1.11 | -0.79 | -0.59 | -0.36 | Upgrade
|
| Other Unusual Items | 18.83 | 18.83 | 34.65 | 0.52 | 27.07 | 29.65 | Upgrade
|
| Pretax Income | 140.37 | 164.19 | 120.19 | 473.83 | 381.94 | 254.21 | Upgrade
|
| Income Tax Expense | -37.22 | -33.09 | -22.21 | 19.39 | 12.13 | 6.97 | Upgrade
|
| Net Income | 177.6 | 197.28 | 142.4 | 454.44 | 369.81 | 247.24 | Upgrade
|
| Net Income to Common | 177.6 | 197.28 | 142.4 | 454.44 | 369.81 | 247.24 | Upgrade
|
| Net Income Growth | 253.21% | 38.54% | -68.66% | 22.88% | 49.57% | - | Upgrade
|
| Shares Outstanding (Basic) | 429 | 429 | 432 | 429 | 430 | 399 | Upgrade
|
| Shares Outstanding (Diluted) | 429 | 429 | 432 | 433 | 430 | 399 | Upgrade
|
| Shares Change (YoY) | -0.64% | -0.61% | -0.30% | 0.65% | 7.83% | 3.44% | Upgrade
|
| EPS (Basic) | 0.41 | 0.46 | 0.33 | 1.06 | 0.86 | 0.62 | Upgrade
|
| EPS (Diluted) | 0.41 | 0.46 | 0.33 | 1.05 | 0.86 | 0.62 | Upgrade
|
| EPS Growth | 255.48% | 39.39% | -68.57% | 22.09% | 38.71% | - | Upgrade
|
| Free Cash Flow | -39.43 | -190.4 | 99.8 | 312.48 | 282.93 | 150.74 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.44 | 0.23 | 0.72 | 0.66 | 0.38 | Upgrade
|
| Dividend Per Share | 0.180 | 0.180 | 0.100 | 0.320 | 0.180 | 0.125 | Upgrade
|
| Dividend Growth | 80.00% | 80.00% | -68.75% | 77.78% | 44.00% | - | Upgrade
|
| Gross Margin | 59.87% | 60.16% | 60.96% | 66.03% | 64.59% | 63.09% | Upgrade
|
| Operating Margin | 5.15% | 4.82% | 5.01% | 21.59% | 18.21% | 14.97% | Upgrade
|
| Profit Margin | 7.53% | 8.54% | 7.07% | 21.43% | 20.98% | 17.11% | Upgrade
|
| Free Cash Flow Margin | -1.67% | -8.25% | 4.96% | 14.74% | 16.05% | 10.44% | Upgrade
|
| EBITDA | 205.78 | 192 | 167.7 | 507.71 | 356.61 | 247.77 | Upgrade
|
| EBITDA Margin | 8.72% | 8.32% | 8.33% | 23.95% | 20.23% | 17.15% | Upgrade
|
| D&A For EBITDA | 84.23 | 80.73 | 66.74 | 50.03 | 35.62 | 31.56 | Upgrade
|
| EBIT | 121.55 | 111.27 | 100.97 | 457.68 | 320.99 | 216.21 | Upgrade
|
| EBIT Margin | 5.15% | 4.82% | 5.01% | 21.59% | 18.21% | 14.97% | Upgrade
|
| Effective Tax Rate | - | - | - | 4.09% | 3.18% | 2.74% | Upgrade
|
| Revenue as Reported | 2,309 | 2,309 | 2,014 | 2,120 | 1,763 | 1,445 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.